New Ebola vaccine trials begin in Uganda amid deadly DR Congo outbreak

Wessam Mankoula, an Africa CDC official, said during an online press briefing that Phase Ib trials of the ChAdOx1 BDBV vaccine, developed by the University of Oxford, began in Uganda on October 6, following the launch of Phase Ia trials in Britain in July.